What is ezetimibe simvastatin used for?
Ezetimibe and simvastatin is a combination medicine that is used to lower blood levels of “bad” cholesterol (low-density lipoprotein, or LDL), to increase levels of “good” cholesterol (high-density lipoprotein, or HDL), and to lower triglycerides (a type of fat in the blood).
What are the side effects of Simvastatin Ezetimibe?
Common side effects may include:
- headache;
- muscle pain;
- abnormal liver function tests;
- diarrhea; or.
- cold symptoms such as stuffy nose, sneezing, sore throat.
How long does ezetimibe and simvastatin take to work?
Most people with high cholesterol or triglycerides do not feel sick. It is very important to continue to follow your doctor’s advice about diet and exercise. It may take up to 4 weeks before you get the full benefit of this drug.
Is weight gain a side effect of ezetimibe?
Patients who have had to discontinue a statin medicine due to muscle aches and pain are often prescribed Ezetimibe due to its lower risk of this side effect. Bottom line: Ezetimibe does not cause weight gain or weight loss.
Is it safe to take simvastatin and ezetimibe?
Using these medicines together with ezetimibe and simvastatin may increase your risk of muscle injury and could result in kidney problems.
Is ezetimibe bad for your liver?
Ezetimibe, alone or associated to statins, may produce serious toxic hepatitis. Caution should be taken and the necessity of analytical follow-up after beginning or during the treatment with ezetimibe is unknown. A prompt withdrawal of the drug is mandatory in case of a significant abnormality in liver tests.
What are the side effects of Inegy?
Hide table of contents
| System organ class Frequency | Adverse reaction |
|---|---|
| Gastrointestinal disorders | |
| Uncommon | abdominal pain; abdominal discomfort; abdominal pain upper; dyspepsia; flatulence; nausea; vomiting; abdominal distension; diarrhoea; dry mouth; gastroesophageal reflux disease |
Which is better ezetimibe or simvastatin?
Simvastatin treatment increased the number of functionally active endothelial progenitor cells, whereas ezetimibe had no effect. Conclusions— Four weeks of simvastatin treatment improves endothelial function independently of LDL cholesterol lowering, at least in part by reducing oxidant stress.